Literature DB >> 2801314

Structure-activity relationships of a series of anti-inflammatory benzisoselenazolones (BISAs).

M J Parnham1, J Biedermann, C Bittner, N Dereu, S Leyck, H Wetzig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2801314     DOI： 10.1007/bf01972806

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


× No keyword cloud information.
  4 in total

Review 1.  Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions.

Authors:  M J Parnham; E Graf
Journal:  Biochem Pharmacol       Date:  1987-10-01       Impact factor: 5.858

2.  Improvement of the gastric tolerance of non-steroidal anti-inflammatory drugs by polyene phosphatidylcholine (Phospholipon 100).

Authors:  S Leyck; N Dereu; E Etschenberg; M Ghyczy; E Graf; J Winkelmann; M J Parnham
Journal:  Eur J Pharmacol       Date:  1985-10-29       Impact factor: 4.432

3.  A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen).

Authors:  A Müller; E Cadenas; P Graf; H Sies
Journal:  Biochem Pharmacol       Date:  1984-10-15       Impact factor: 5.858

4.  A novel biologically active seleno-organic compound--II. Activity of PZ 51 in relation to glutathione peroxidase.

Authors:  A Wendel; M Fausel; H Safayhi; G Tiegs; R Otter
Journal:  Biochem Pharmacol       Date:  1984-10-15       Impact factor: 5.858
  4 in total
  2 in total

Review 1.  The pharmacology of ebselen.

Authors:  M J Parnham; S Leyck; E Graf; E J Dowling; D R Blake
Journal:  Agents Actions       Date:  1991-01

2.  High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S).

Authors:  Brice A P Wilson; Haofan Wang; Benjamin A Nacev; Ronnie C Mease; Jun O Liu; Martin G Pomper; William B Isaacs
Journal:  Mol Cancer Ther       Date:  2011-03-25       Impact factor: 6.261
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.